151 related articles for article (PubMed ID: 32491269)
1. Testosterone replacement therapy in insulin-sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism.
Fanelli G; Belardo A; Savino R; Rinalducci S; Zolla L
J Cell Mol Med; 2020 Jul; 24(14):8266-8269. PubMed ID: 32491269
[TBL] [Abstract][Full Text] [Related]
2. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
[TBL] [Abstract][Full Text] [Related]
3. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
4. Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men.
Angelova P; Momchilova A; Petkova D; Staneva G; Pankov R; Kamenov Z
Aging Male; 2012 Sep; 15(3):173-9. PubMed ID: 22776010
[TBL] [Abstract][Full Text] [Related]
5. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.
Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L
Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
7. Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men.
Maseroli E; Comeglio P; Corno C; Cellai I; Filippi S; Mello T; Galli A; Rapizzi E; Presenti L; Truglia MC; Lotti F; Facchiano E; Beltrame B; Lucchese M; Saad F; Rastrelli G; Maggi M; Vignozzi L
J Endocrinol Invest; 2021 Apr; 44(4):819-842. PubMed ID: 32772323
[TBL] [Abstract][Full Text] [Related]
8. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
[TBL] [Abstract][Full Text] [Related]
10. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
Morrison BF; Reid M; Madden W; Burnett AL
Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
[TBL] [Abstract][Full Text] [Related]
11. Testosterone replacement therapy restores normal ghrelin in hypogonadal men.
Pagotto U; Gambineri A; Pelusi C; Genghini S; Cacciari M; Otto B; Castañeda T; Tschöp M; Pasquali R
J Clin Endocrinol Metab; 2003 Sep; 88(9):4139-43. PubMed ID: 12970277
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Testosterone Replacement Therapy on Penile Hemodynamics in Hypogonadal Men With Erectile Dysfunction, Having Veno-Occlusive Dysfunction.
Efesoy O; Çayan S; Akbay E
Am J Mens Health; 2018 May; 12(3):634-638. PubMed ID: 29575969
[TBL] [Abstract][Full Text] [Related]
13. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
Lundy SD; Parekh NV; Shoskes DA
J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
[TBL] [Abstract][Full Text] [Related]
14. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study).
Shigehara K; Konaka H; Koh E; Nakashima K; Iijima M; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Sugimoto K; Iwamoto T; Mizokami A; Namiki M
Aging Male; 2017 Sep; 20(3):139-145. PubMed ID: 28347184
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
[TBL] [Abstract][Full Text] [Related]
16. Late-Onset Hypogonadism and Testosterone Replacement in Older Men.
Bhattacharya RK; Bhattacharya SB
Clin Geriatr Med; 2015 Nov; 31(4):631-44. PubMed ID: 26476121
[TBL] [Abstract][Full Text] [Related]
17. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
Bondanelli M; Ambrosio MR; Margutti A; Franceschetti P; Zatelli MC; degli Uberti EC
Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
[TBL] [Abstract][Full Text] [Related]
18. Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).
Shigehara K; Konaka H; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Iwamoto T; Koh E; Mizokami A; Namiki M
Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497534
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of testosterone on whole body protein metabolism in hypogonadal and eugonadal conditions: a randomized, placebo-controlled, crossover study.
Ornstrup MJ; Høst C; Rittig N; Gravholt CH
J Appl Physiol (1985); 2024 Jun; 136(6):1460-1467. PubMed ID: 38634506
[TBL] [Abstract][Full Text] [Related]
20. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
Johansen KL
Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]